GlassScriptPhysician profile
Charles Thompson
NPI 1972999035
$844.38
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $172 · 2021: $190 · 2022: $31.89.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $161.78 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $125.30 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.90 | 2019-2021 | |
| Novo Nordisk INC | $78.59 | 2019-2021 | |
| Amgen INC. | $64.81 | 2019-2022 | |
| Lilly USA, LLC | $58.93 | 2019-2020 | |
| Abbvie INC. | $46.03 | 2019-2021 | |
| Allergan, INC. | $35.72 | 2019-2020 | |
| Amarin Pharma, INC. | $28.10 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $26.39 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.33 | 2021 | |
| Sanofi-Aventis U.S. LLC | $24.77 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $24.05 | 2021 | |
| Abbott Laboratories | $18.43 | 2022 | |
| Paratek Pharmaceuticals, INC. | $15.57 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $12.87 | 2020 | |
| Dexcom, INC. | $12.81 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Thompson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.